Clinical Scorecard: Exploring Digital Reminiscence to Alleviate Pre-Death Grief in Family Caregivers of Dementia Patients: A Pilot Randomized Study
At a Glance
Category
Detail
Condition
Predeath grief in family caregivers of patients with Alzheimer disease or related dementias (ADRD)
Key Mechanisms
Digital reminiscence therapy promoting autobiographical memory recall and collaborative engagement to strengthen relational bonds and reduce caregiver distress
Target Population
Family caregivers aged 18 or older providing primary care to community-dwelling individuals with mild to moderate ADRD
Care Setting
Community and virtual settings
Key Highlights
Predeath grief involves mourning and relational deprivation experienced by caregivers before the death of ADRD patients, negatively impacting mental health and decision-making.
Digital reminiscence therapy (Living Memory Home for Dementia Care Pairs [LMH-4-DCP]) adapts a bereavement platform to support caregiver-care recipient dyads through life story documentation and reflective activities.
The pilot randomized clinical trial demonstrated feasibility, acceptability, and preliminary efficacy of a 2-week digital reminiscence intervention delivered virtually.
Guideline-Based Recommendations
Diagnosis
Assess caregiver experiences of predeath grief characterized by longing, yearning, and role confusion prior to patient death.
Evaluate disease stage of care recipient (mild to moderate ADRD) to determine intervention suitability.
Management
Implement digital reminiscence therapy interventions that facilitate autobiographical memory recall and collaborative engagement between caregiver and care recipient.
Use strengths-based, meaning-centered approaches to preserve connection and reduce caregiver distress.
Monitoring & Follow-up
Monitor caregiver psychological outcomes including depression, anxiety, burden, and grief severity before and after intervention.
Collect feedback on intervention acceptability and feasibility to guide ongoing care.
Risks
Consider exclusion of caregivers with cognitive impairment or those caring for patients with advanced ADRD who may not benefit from digital reminiscence therapy.
Be aware of potential technological barriers such as lack of computer or internet access.
Patient & Prescribing Data
Family caregivers of community-dwelling patients with mild to moderate ADRD in the United States fluent in English with internet access.
A 2-week virtual reminiscence therapy intervention is feasible and acceptable, showing preliminary efficacy in reducing predeath grief and improving caregiver-care recipient relationships.
Clinical Best Practices
Screen caregivers for predeath grief and relational deprivation early in ADRD caregiving trajectory.
Incorporate digital reminiscence therapy as a supportive intervention to foster emotional connection and meaning making.
Ensure demographic balance and inclusivity by considering race, ethnicity, and sex in intervention delivery and evaluation.
Use virtual platforms to reduce participant burden and increase accessibility.
by Francesca B. Falzarano, Annabelle Greenfield, Sydney C. Saviano, Sindhu Kolla, Sosi Korian, Francesco Osso, Joseph Miller, Heather E. Whitson, Paul K. Maciejewski, Holly G. Prigerson
